Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors Meeting Abstract


Authors: Hong, D. S.; SciMentum, S. L.; Tanyi, J.; MacMullen, L.; Jalbert, L.; Muzithras, V. P.; Zikaras, K.; Cao, L.; O'Cearbhaill, R. E.; Quintás-Cardama, A.; Hassan, R.
Abstract Title: Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S830
Language: English
ACCESSION: WOS:000700527701422
DOI: 10.1016/j.annonc.2021.08.1344
PROVIDER: wos
Notes: Meeting Abstract #959O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors